Multiple System Atrophy Market: Current Analysis and Forecast (2023-2030)

Report Description

The Multiple System Atrophy Market was valued at USD 125 Million and is expected to grow at a strong CAGR of around 4% during the forecast period (2023-2030). Multiple system atrophy is a progressive neurogenerative disorder which leads to damage in the nerve cells. It leads to deterioration or shrinking of specific parts of brain, mainly motor or autonomic regions. Multiple system atrophy market is propelled by rising cases of neurogenerative disorders. The prevalence of neurogenerative disorders is expected to double in the coming two decades as per NCBI reports 2023. The National Library of Medicine reports multiple system atrophy as a disorder which has an incidence rate of 0.1-3 per 100,000 people depending upon particular age and geography. Absence of promising mode of diagnosis and treatment of multiple system atrophy has led to an open door of opportunities for pharmaceutical companies in the market. The rising number of clinical trials focusing on new therapies is driving the growth of the market. For instance, on March 2023, Inhibikase Therapeutics recently got FDA approval for phase 2a “202” clinical trial IkT-148009, which is an Abelson Tyrosine Kinase (c-Abl) inhibitor. This drug has shown neuroprotective advantage and prevention of functional loss in initial preclinical trials on mice.

Some of the major players operating in the Biohaven, Ltd.; Theravance Biopharma; Sumitomo Dainippon Pharma Co., Ltd.; Alterity Therapeutics; AstraZeneca; Biogen; Merck & Co., Inc.; Neuropore Therapies, Inc.; WaveBreak Therapeutics; Newron Pharmaceuticals SPA. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

“Amongst types, the parkinsonian segment to hold predominant share during the forecast period”

Based on the types, the market is bifurcated into parkinsonian and cerebellar multiple system atrophy. Parkinsonian MSA or MSA-P held predominant share in the market in 2022. MSA-P is identified from several symptoms like stiffness, tremor with difficulty in coordination and balance. MSA-P holds a higher progression rate than MSA-C. Patients suffering from MSA-P survive a relatively shorter lifespan. The incidence and prevalence of Multiple system atrophy – parkinsonian is 0.6 to 0.7 cases per 100,000 as per Cureus reports of year 2020. Pharmaceutical companies are competing to find a cure for this incurable disorder. For example, Lundbeck pharmaceutical company launched phase 2 to evaluate efficacy of drug Lu AF82422 versus Placebo on patients suffering from MSA in November 2021.

“Amongst diagnosis, the MRI category to grow with high CAGR during the forecast period”

By application, the market is categorized into magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), tilt table test and others. MRI is anticipated to grow with high CAGR during the forecast period. Multiple companies are launching their modified versions of MRIs. Recently, Siemens has launched new MRI scanners named 3T MRI scanners which use immensely powerful magnets to generate magnetic field twice as strong as traditional MRI scanners in November 2022.  This scanner has the ability to generate clearer images of specific areas of the brain.

“Amongst end-user, the hospitals category to held significant share of the market in 2022”

Based on end use, the market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals held a significant share of the market in 2022. Hospitals serve as primary healthcare institutions where MSA patients receive diagnosis, treatment, and ongoing care. They play a pivotal role in the management of MSA by providing state-of-the-art medical facilities, specialized expertise, and a multidisciplinary approach to patient care. The hospitals offer treatment to many patients, allowing them to capitalize on economies of scale and offer more efficient and cost-effective services. Financial incentives from health insurance companies are also a major factor, as these can reduce the cost of treatment and make it more affordable for patients.

“Asia Pacific to grow with high during the forecast period”

The Asia Pacific is anticipated to grow rapidly in the upcoming years owing to the surge in the prevalence of multiple system atrophy and the encouraging response of multiple system atrophy in its management. Rising geriatric population in highest populated countries of Asia Pacific region- China and India indicates towards upcoming surge in MSA cases in the region. China being the highest in the list accounts for highest upcoming geriatric population. India is the second target for Multiple system atrophy market.

Multiple System Atrophy Market Report Coverage

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:

The global multiple system atrophy market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team

Research Methodology

Research Methodology for the Multiple System Atrophy Market Analysis (2023-2030)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global multiple system atrophy market were the three major steps undertaken to create and analyze the adoption of multiple system atrophy in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global multiple system atrophy market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the multiple system atrophy market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the multiple system atrophy market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as types, diagnosis, age and end use. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the multiple system atrophy market. Further, we conducted factor analysis using dependent and independent variables such as types, diagnosis, age and end use of the multiple system atrophy market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the multiple system atrophy market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global multiple system atrophy market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

• The industry’s market size, in terms of revenue (USD) and the adoption rate of the multiple system atrophy market across the major markets domestically
• All percentage shares, splits, and breakdowns of market segments and sub-segments
• Key players in the global multiple system atrophy market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global multiple system atrophy market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the types, diagnosis, age and end use in the global multiple system atrophy market.

The main objective of the Global Multiple System Atrophy Market Study

The current & future market trends of the global multiple system atrophy market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

• Analyze the current and forecast market size of the multiple system atrophy market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
• Segments in the study include areas of the types, diagnosis, age and end use
• Define and analysis of the regulatory framework for the multiple system atrophy industry
• Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
• Analyze the current and forecast market size of the multiple system atrophy market for the major region
• Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
• Company profiles of the multiple system atrophy market and the growth strategies adopted by the market players to sustain in the fast-growing market
• Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team